UNSPSC 51182019: Androstenedione

This classification denotes an anabolic steroid with the molecular formula C19H26O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 409J2J96VR, chemically known as 3,17-dioxoandrost-4-ene but generally known as androstenedione, which bears US NIH Compound Identifier 6128. European Medicines Agency schedules Androstenedione in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12900MIG. As of Q4 2014, ANDROSTENEDIONE remains the US FDA Preferred Term for this commodity.

Androstenedione bears US NLM identifiers UMLS ID CL026907 and NCI Concept Code C2300. SMILES: O=C1C2(C(C3C(C4(C(=CC(=O)CC4)CC3)C)CC2)CC1)C..

UNSPSC 51182019 Androstenedione is a Commodity code covering the procurement of androstenedione, a pharmaceutical precursor and performance-enhancing steroid compound. State and local governments purchase this substance primarily for laboratory testing, forensic analysis, and regulatory compliance programs where detection and identification of the compound in biological samples is operationally necessary. The code sees activity from state health departments, forensic laboratories operated by state attorneys general or state police, and county medical examiner offices responsible for toxicology screening and controlled-substance enforcement. School districts with athletic drug-testing programs and correctional agencies also procure under this code as part of substance-abuse monitoring protocols.

The source provided does not include a recent opportunities block, and accordingly no recent state or local solicitations, issuing bodies, geographic spread, or response dates can be identified. No current procurement activity under this code is documented.